COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 1289: Articles 12881-12890  | Next

Autoantibodies against IL-1-receptor-antagonist in multisystem inflammatory syndrome in children
Pfeifer, J., Thurner, B., Kessel, C., Fadle, N., Regitz, E., Hoffmann, M.-C., Kos, I., Preuss, K.-D., Fischer, Y., Roemer, K., Lohse, S., Heyne, K., Detemple, M.-C., Fedlmeier, M., Juenger, H., Sauer, H., Meyer, S., Rohrer, T., Wittkowski, H., Masjosthusmann, K., Becker, S. L., Smola, S., Bewarder, M., Boehm, M., Anton, J., Pino-Ramirez, R. M., Abdul-Khaliq, H., Foell, D., Thurner, L.
10.1101/2021.09.08.21263027 — Posted: 2021-09-12
Determinants of early antibody responses to COVID-19 mRNA vaccines in exposed and naive healthcare workers
Moncunill, G., Aguilar, R., Ribes, M., Ortega, N., Rubio, R., Salmeron, G., Molina, M. J., Vidal, M., Barrios, D., Mitchell, R. A., Jimenez, A., Castellana, C., Hernandez-Luis, P., Rodo, P., Mendez, S., Llupia, A., Puyol, L., Rodrigo Melero, N., Carolis, C., Mayor, A., Izquierdo, L., Varela, P., Trilla, A., Vilella, A., Barroso, S., Angulo, A., Engel, P., Tortajada, M., Garcia-Basteiro, A. L., Dobano, C.
10.1101/2021.09.08.21263232 — Posted: 2021-09-12
The statistical analysis of daily data associated with different parameters of the New Coronavirus COVID-19 pandemic in Georgia and their two-week interval prediction in summer 2021
Amiranashvili, A. G., Khazaradze, K. R., Japaridze, N. D.
10.1101/2021.09.08.21263265 — Posted: 2021-09-12
Four-week forecasts of COVID-19 epidemic trajectories in South Africa, Chile, Peru and Brazil: a model evaluation
Delva, W., Dominic, E., Beauclair, R., Ouifki, R., Kroon, M., Volmink, H., Dorkin, E.
10.1101/2021.09.06.21263151 — Posted: 2021-09-12
Street images classification according to COVID-19 risk in Lima, Peru: A convolutional neural networks analysis
Carrillo-Larco, R. M., Hernandez Santa Cruz, J. F.
10.1101/2021.09.06.21263188 — Posted: 2021-09-12
Incidence of COVID-19 reinfection among Midwestern healthcare employees
Rivelli, A., Fitzpatrick, V., Blair, C., Richards, J., Copeland, K.
10.1101/2021.09.07.21263100 — Posted: 2021-09-12
The efficiency of dynamic regional lockdown approach in controlling the COVID-19 epidemic. Insights from the agent-based epidemiological model for Poland
Zielinski, J., Gruziel-Słomka, M., Nowosielski, J. M., Bartczuk, R. P., Niedzielewski, K., Semeniuk, M., Gorski, Łukasz, Kisielewski, J., Moszynski, A., Radwan, M., Kaczorek, A., Rakowski, F.
10.1101/2021.09.06.21263031 — Posted: 2021-09-12
Reduced magnitude and durability of humoral immune responses by COVID-19 mRNA vaccines among older adults
Brockman, M. A., Mwimanzi, F. M., Lapointe, H. R., Sang, Y., Agafitei, O., Cheung, P., Ennis, S., Ng, K., Basra, S., Lim, L. Y., Yaseen, F., Young, L., Umviligihozo, G., Omondi, F. H., Kalikawe, R., Burns, L., Brumme, C. J., Leung, V., Montaner, J., Holmes, D., DeMarco, M., Simons, J., Pantophlet, R., Niikura, M., Romney, M. G., Brumme, Z. L.
10.1101/2021.09.06.21263149 — Posted: 2021-09-12
Exposures to different SARS-CoV-2 spike variants elicit neutralizing antibody responses with differential specificity towards established and emerging strains
Laurie, M. T., Liu, J., Sunshine, S., Peng, J., Black, D., Mitchell, A. M., Mann, S. A., Pilarowski, G., Zorn, K. C., Rubio, L., Bravo, S., Marquez, C., Petersen, M., Havlir, D., DeRisi, J.
10.1101/2021.09.08.21263095 — Posted: 2021-09-12
Analysis of SARS-CoV-2 variants from 24,181 patients exemplifies the role of globalisation and zoonosis in pandemics
Colson, P., Fournier, P.-E., Chaudet, H., Delerce, J., GIRAUD-GATINEAU, A., HOUHAMDI, L., ANDRIEU, C., BRECHARD, L., BEDOTTO, M., PRUDENT, E., GAZIN, C., BEYE, M., BUREL, E., DUDOUET, P., TISSOT-DUPONT, H., GAUTRET, P., LAGIER, J.-C., MILLION, M., BROUQUI, P., Parola, P., Drancourt, M., LA SCOLA, B., LEVASSEUR, A., Raoult, D.
10.1101/2021.09.10.21262922 — Posted: 2021-09-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).